Park Ha Biological Technology Co., Ltd., (NASDAQ:BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the "Company"), today announced that it has entered into a securities purchase agreement with several investors for the sales of the Company's securities in a registered direct offering (the "Offering") consisting of up to 1,133,332 of the Company's Class A ordinary shares, par value $0.001 each (the "Shares"), and pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 200,000 Class A ordinary shares (the "Warrant Shares"), at a combined purchase price of $1.50 per Share and Pre-Funded Warrant. The gross proceeds to the Company from this Offering are expected to be approximately $2.0 million.

The Offering is expected to close on or about June 15, 2026, subject to customary closing conditions.

D. Boral Capital LLC is acting as the sole placement agent for the offering.

The Company intends to use the net proceeds from this Offering for general corporate and working capital purposes.